{"name":"Famy Life Sciences, a Viatris Company","slug":"famy-life-sciences-a-viatris-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxOZ3k4STJFRlJKX3NYSW85aXc4NC1aY25MN3VRVVgwVkJYWUNjTDRxcnBoWTh5Y1JIczJaNS1rSmtLRzk5MWxKTHBCWV9wUFdvVmZkbnF1cHc5TXBKbV9tajFHb05UZXBPYk1GQ0FUZnNWUFNvaENhR3ViVVE1a1B2S05mOGNxdnp0WThNazlPSWFnbEUwV1luckw1Y2FJeC1jNE1KZjhwcTBzaV9fd2lVaHFzVVY2eDBJQXhVM1lzUVNMdkVSUGdjMk5Tb3libDRrOHItR0s0dzdYTnRWQVJ4eThiQnA0dw?oc=5","date":"2026-02-10","type":"patent","source":"FinancialContent","summary":"Viatris at a Crossroads: Transitioning from Generic Giant to Specialty Powerhouse - FinancialContent","headline":"Viatris at a Crossroads: Transitioning from Generic Giant to Specialty Powerhouse","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-01-04","type":"pipeline","source":"medicaldialogues.in","summary":"Viatris closes acquisitions of Famy Life Sciences, Oyster Point Pharma to establish eye care division - medicaldialogues.in","headline":"Viatris closes acquisitions of Famy Life Sciences, Oyster Point Pharma to establish eye care division","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxOc3dLSjcyZTdBWGlMV3ZGNVUtUW5mdzRvMDZDbVBHWUZZSUpoQVpVaF9QclZQazV0dHd2Z21VSnRXTFQ0U3VJcHBpRmg3eVFzSnFvLXVBN05YTERJY1V1c0dUZmVzcnk4NFk5akZzcW5CZnlCcFcwa1dMTHVNaDRzWEpZbzE1YTZET0xwMEVWT3YyMzY1cmJFdXRNSkdpSnFRYk1jZ05KLV8xSDJFN1YyVDZOLVZqdGpEamw3T1gzblhsUEpiWGtjY3JVLWtwc0RiYWk2Ui1nV2hoMUVuLTJHTm1TdXBqWnB2UXI3bzJ0Q0pQM1pEZzhNMC1qUkswWndpVlE?oc=5","date":"2023-01-03","type":"pipeline","source":"PR Newswire","summary":"Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishing New Viatris Eye Care Division - PR Newswire","headline":"Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishing New Viatris Eye Care Division","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNb1RpQXg0MGpaRTFqVW1VTlJpUkFmdzZTbUVlbzZsNUFSS01Ecm5MaEpTT2RoXzJnOWRDQWJaNnVrWlNiMUo4bWNjWlBvSnhhTXZoN2UyT0RDd0NkS19qY3pxQVNoQ29oMERKcWgzZzFwYVdWdXNvcS01cWQxYkQ2Y3FETHNacjJjX0xERzBOWkZhZGNNTXVpbXZTVzNWdjhNeWhMeVdMcXdjelV3?oc=5","date":"2023-01-03","type":"deal","source":"Eyes On Eyecare","summary":"Viatris officially acquires Oyster Point Pharma, Famy Life Sciences - Eyes On Eyecare","headline":"Viatris officially acquires Oyster Point Pharma, Famy Life Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNcFluYVpuOXZaSk5BYVo5Q0tpb2wyZEk1OVo5MVc5cWV2dkZYcWFTb28tT01SM1dpMWsyUmozRGdETnJWNklXUFl5bmpyemJtTlktMFBhNUdmbEJTMUw3cU5oOC0xZk1NSlVNZGExRm83aE9pQnE0V3I1YjdlTUoxLTJpSnR3ZkZFWVpyVkw0eVJxYWhnZ3YzVkF2YTc3QU5HY3pxOHd4eC01eXpXNWY0SF9HYw?oc=5","date":"2022-11-10","type":"pipeline","source":"White & Case LLP","summary":"White & Case Advises Famy Life Sciences on Its Acquisition by Viatris Inc. - White & Case LLP","headline":"White & Case Advises Famy Life Sciences on Its Acquisition by Viatris Inc. - White & Case LLP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE1zc2poUFFaQzVnX2ZsTFJaWjBCbWNtVUpnb1FiNXM5T3ZlaS1mZkstaU85MDJkQ2pDQVd5ay1pdkV5VFRpemQ4TGdTMi1PUVY0eDQwLWk5ZzdaWGtQSEtycFkxdE5lQW0xaVk3VUFWaTVwZUlKendfcWkzNGJvUQ?oc=5","date":"2022-11-08","type":"deal","source":"Pharmaceutical Technology","summary":"Viatris agrees to acquire Oyster Point and Famy Life Sciences - Pharmaceutical Technology","headline":"Viatris agrees to acquire Oyster Point and Famy Life Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNUGZLNkhVMG5vRUVhblRmY2dRcC1pc3NtREtubXF5U2d4TUdBUl9CQkE2X2RmT0xKVTRJN19sckRGQUZsQXJnd1F5M0g2eENTVnQzX252SHBpazEyOGdJZ0VqS2t5TGl2ZTB4MTY1bGpfeEdReHBFTDZVVXVsS2FSaERuZE1qTlRRQnA1cnR6bGN3NnRw?oc=5","date":"2022-11-07","type":"deal","source":"BioPharma Dive","summary":"Viatris to buy two eye drug developers in deals worth up to $750M - BioPharma Dive","headline":"Viatris to buy two eye drug developers in deals worth up to $750M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQSFJqYnRkNVFsSzN5TGRCaFY0amRGbHdpbG12VVNiNDlteThzYjJRUzVEdE5BUHRLVmRKZHhDdFBrcllwVHJMeHZqR3NBU0Z4dE53MzBQLXpxSUd2aThaaXUxSG5uUjNEeDFSOWFXakVCWk1nMWtZUzJMRkNVa01OU0U1YmNrZE1JNWF3X0ktOW94Z2ZHTkJ5RGVremNKcFdMWjE3anFNVnd0VWh3SjVKeGxiTzBVRmNrVWhuUE5KdUFWdnktZTE4?oc=5","date":"2022-11-07","type":"deal","source":"Fierce Pharma","summary":"Viatris jumps into ophthalmology arena with pair of buyouts worth up to $750M - Fierce Pharma","headline":"Viatris jumps into ophthalmology arena with pair of buyouts worth up to $750M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxObjY4UWFJcVVfWnJ3SzZSV3ByWUdKRGFlQXN3Q0tuMV8xSWowemhEMnN5ajhzdzhhZmVzdGU2Tk80cFAzTW9BTWhWYUhnODI3VlFVTjJJLXh3bHRYS0o4TjBUc2ZmdkppMldWNm44dWQxemlnUzVVNXh5QU80WWZ0NnE2TlY4TXhSaTV4YWdTQjF3QTFTdTJQbEdSNExvOG8?oc=5","date":"2022-11-07","type":"deal","source":"citybiz","summary":"Viatris Acquires Oyster Point Pharma and Famy Life Sciences - citybiz","headline":"Viatris Acquires Oyster Point Pharma and Famy Life Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQVTBjSW5TYVFGMnRodFQxZzNvQ2xmNXgxdThxenVvSFdGaWVJeXVZQUJaUllXeUdPUWY2ZUxtNmNmVVgwa0FHcW5PT1ZPUGhtM2hWelhqVnd3a1FxUnZhd29xOEthZ3d4cGxQTVdDRGZsMWF0MGFDQzFXdmlud21Ec3pWUGdiZGN2MlprX3dVOFRVLTBVX0NuNHhRdlUtVmctMUk0U3lielhMYTBiY0tMZ1dnRQ?oc=5","date":"2022-11-07","type":"pipeline","source":"Ophthalmology Times","summary":"Viatris making ophthalmology push with acquisition of Oyster Point Pharma - Ophthalmology Times","headline":"Viatris making ophthalmology push with acquisition of Oyster Point Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOYkwtWno5SFIxV0FWUl9JQVFzN0hJOUtULXBSQndpeG5MT0ZJenY3WUJWZzJtc1BTcWN3dDBFS19tNGNwNnBwUGhnNWJjYTU2UWZEckl4SmRrRHpmVjE3U1dTbGJfRi11a3MtWFl4a1gwVmdBREdJRVhWRFp2dHA2dTF5YzFoUFo0RFZKamlfcDRkaWhsdWZ2SXBJTWRRcVV1eXNsMHV0WUI3VzM5?oc=5","date":"2022-11-07","type":"deal","source":"MedCity News","summary":"Viatris Sees Vision Drugs as Key to Growth and Commits $750M to Two M&A Deals - MedCity News","headline":"Viatris Sees Vision Drugs as Key to Growth and Commits $750M to Two M&A Deals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxNZUlUOFRYVkVmbFRwQ0t5Vm1nY25UbXVVeDJ5b1dsMEl3akxBLVZzeWZFT044NGtBRUthRG04ZEJwanJRYjQwSHUwTkpsdjZ0bjRPNV9RMURSMVl4azJBbVpWVlhJTHZSVW9QWmRzY2VhQlgzc2E1UGRsQzVWQThaajdkcjhWNExrWC1EaFFOdVBTSVBrUkRSRXROUWpva1F5akRiRVpYUEtaQkNWWHEtbHVBOHFyR29sUEN5Y2lDYkh0c2ZZZEN2T1JZU09NMVVyVE94U2xpY1h3eDJaS2RaNkJ3dGcwMzN3cTZFaksxMXp2UXZ4aVVLNm1WZHR5TXFRUUMtOWFVMElkVDNNOVBacWExSGE1cmltYnRQeVJmemdVMWpKV28wYlVOaXV0dE41WU9uNkZiRHRqWmt5TTlUdUZ6WmhlbW9JcHc?oc=5","date":"2022-11-07","type":"pipeline","source":"PR Newswire","summary":"Viatris Announces Two Acquisitions to Create What it Expects to be a Leading Ophthalmology Franchise; Plans to Provide Strategic Update on its February 2022 Investor Event - PR Newswire","headline":"Viatris Announces Two Acquisitions to Create What it Expects to be a Leading Ophthalmology Franchise; Plans to Provide S","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}